Page last updated: 2024-10-30

metformin and Brain Swelling

metformin has been researched along with Brain Swelling in 1 studies

Metformin: A biguanide hypoglycemic agent used in the treatment of non-insulin-dependent diabetes mellitus not responding to dietary modification. Metformin improves glycemic control by improving insulin sensitivity and decreasing intestinal absorption of glucose. (From Martindale, The Extra Pharmacopoeia, 30th ed, p289)
metformin : A member of the class of guanidines that is biguanide the carrying two methyl substituents at position 1.

Research Excerpts

ExcerptRelevanceReference
"Metformin treatment after SAH promoted mitophagy in an AMPK-dependent manner."5.72Metformin attenuates early brain injury after subarachnoid hemorrhage in rats via AMPK-dependent mitophagy. ( Guo, Y; Li, Y; Liu, B; Shi, H; Tian, Y; Wu, P; Zhang, T; Zhang, Y, 2022)
"Metformin treatment after SAH promoted mitophagy in an AMPK-dependent manner."1.72Metformin attenuates early brain injury after subarachnoid hemorrhage in rats via AMPK-dependent mitophagy. ( Guo, Y; Li, Y; Liu, B; Shi, H; Tian, Y; Wu, P; Zhang, T; Zhang, Y, 2022)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Zhang, Y1
Zhang, T1
Li, Y1
Guo, Y1
Liu, B1
Tian, Y1
Wu, P1
Shi, H1

Other Studies

1 other study available for metformin and Brain Swelling

ArticleYear
Metformin attenuates early brain injury after subarachnoid hemorrhage in rats via AMPK-dependent mitophagy.
    Experimental neurology, 2022, Volume: 353

    Topics: AMP-Activated Protein Kinases; Animals; Apoptosis; Blood-Brain Barrier; Brain Edema; Brain Injuries;

2022